JPRN-UMIN000002446已完成1 期
Radiation dosimetry, safety and pharmacokinetics of [11C]telmisartan as well as optimization of PET imaging in healthy volunteers - Pharmacokinetics of [11C]telmisartan in healthy volunteers (TEL-0)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Renal artery stenosis, bilaterally or unilaterally after nephrectomy 2. Hyperkalemia 3. Liver or renal dysfunction 4. Cerebrovascular disorders 5. Hypotension 6. Severe bradycardia, or WPW or LGL syndrome by ECG 7. Medication or dietary supplement including St. John's wort within 7 days prior to PET study
研究者
相似试验
尚未招募
2 期
Radiation therapy in locally advanced rectal cancerCTRI/2023/10/059109Dr Raju Das
尚未招募
1 期
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid TumorsSolid TumorsNCT06553846Fudan University50
进行中（未招募）
不适用
A dose ranging, safety and pharmacokinetics study of Candesartan Cilexetil in hypertensive pediatric subjects 1 to less than 6 years of age a 4-week, multicenter, randomised, double blind study with a 1 year open-label, follow-up period - NDHypertension in pediatric subjects 10020772MedDRA version: 8.1Level: PTClassification code 10020772Term: HypertensionEUCTR2004-004264-75-ITASTRAZENECA125
已完成
1 期
PK in Pts With HRPC & Skeletal MetastesProstatic NeoplasmsNCT00667537Bayer6
招募中
不适用
Measurement of radiation dose of the patient in neuro angiographycerebral aneurysm, cerebral arteriovenous malformation, dural cerebral arteriovenous fistula etc.JPRN-UMIN000038076Toranomon Hospital300